NSE-BSE bulk deals: Vanguard laps up Dixon; Integrated Core laps up ZEE


Mumbai: Amid the bloodbath on the D-Street on Thursday, foreign investors seem to have lapped up select mid and smallcap stocks. Among the key bulk deals, The Vanguard Group lapped up shares of Dixon Technologies, while Max Life cut its stake in the contract manufacturer.

In other deals, Nalanda India Equity fund lapped up specialty biotech company Advanced Enzyme Technologies, while Integrated Core Strategies (Asia) picked up shares of broadcaster Zee Entertainment.

Of the frontline indices, Sensex tumbled 1,114.82 points to 36,554, while peer Nifty nosedived 326 points to 10,806.

Here’s who bought and sold what in some of the key bulk deals of the day:
>> Max Life Insurance Co sold 65,000 shares of Dixon Technologies at Rs 8,402.01 per share, while The Vanguard Group Inc A/C Vanguard Emerging Markets Stock Index Fund A Series Of V I E I F bought 64,452 shares of the company at Rs 8,402 per share. The insurance company held 1.2 per cent stake in the company at the end of June.

>> Nalanda India Equity Fund bought 41,90,491 shares of Advanced Enzyme Technologies at Rs 263.80 per share, while Advanced Vital Enzymes sold 30,00,000 shares of the company at Rs 265 per share.

>> Plutus Wealth Management bought 25,000 Rushil Décor Rights Entitlements (REs) at Rs 17.05 each, while Swing Infraspace and Margi Jigneshbhai Shah sold 76,803 and 28,051 of such REs respectively.

>> Integrated Core Strategies (Asia) Pte bought 49,63,315 shares of Zee Entertainment Enterprises at Rs 190.53 per share

>> Dillip Kumar Das bought 72,000 shares of Alfa Transformers at Rs 14.13 per share. Das held 14.68 per cent stake in the company at the end of June.

Here are all the BSE bulk deals:

bse bulk deals 1 (18)
bse bulk deals 2 (24)

Here are all the NSE bulk deals:

nse bulk deals 1 (15)
nse bulk deals 2 (15)


Source link

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top
Need Help? Chat with us
Please accept our privacy policy first to start a conversation.